{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:32:33Z","timestamp":1788870753074,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,1,2]],"date-time":"2016-01-02T00:00:00Z","timestamp":1451692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes","doi-asserted-by":"crossref","award":["IV-101-PP-01"],"award-info":[{"award-number":["IV-101-PP-01"]}],"id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes","doi-asserted-by":"crossref","award":["IV-101-PP-02"],"award-info":[{"award-number":["IV-101-PP-02"]}],"id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.jmii.2014.01.005","type":"journal-article","created":{"date-parts":[[2014,3,22]],"date-time":"2014-03-22T20:11:43Z","timestamp":1395519103000},"page":"52-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Carbapenem-resistant Pseudomonas aeruginosa in Taiwan: Prevalence, risk factors, and impact on outcome of infections"],"prefix":"10.1016","volume":"49","author":[{"given":"Kuan-Yin","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsai-Ling","family":"Lauderdale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jann-Tay","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Chwen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2014.01.005_bib1","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1086\/377200","article-title":"Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome","volume":"37","author":"Kang","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2014.01.005_bib2","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1086\/317448","article-title":"Hospital outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-1, a novel transferable metallo-beta-lactamase","volume":"31","author":"Cornaglia","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2014.01.005_bib3","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1128\/JCM.38.3.1290-1292.2000","article-title":"Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece","volume":"38","author":"Tsakris","year":"2000","journal-title":"J Clin Microbiol"},{"issue":"47","key":"10.1016\/j.jmii.2014.01.005_bib4","doi-asserted-by":"crossref","DOI":"10.2807\/ese.13.47.19045-en","article-title":"Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe","volume":"13","author":"Souli","year":"2008","journal-title":"Euro Surveill"},{"key":"10.1016\/j.jmii.2014.01.005_bib5","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ajic.2004.10.001","article-title":"National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004","volume":"32","year":"2004","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.jmii.2014.01.005_bib6","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1128\/AAC.48.12.4606-4610.2004","article-title":"National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002","volume":"48","author":"Obritsch","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2014.01.005_bib7","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1093\/jac\/dkt098","article-title":"Complexity of resistance mechanisms to imipenem in intensive care unit strains of Pseudomonas aeruginosa","volume":"68","author":"Fournier","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2014.01.005_bib8","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1086\/444469","article-title":"Population-based epidemiological study of infections caused by carbapenem-resistant Pseudomonas aeruginosa in the Calgary Health Region: importance of metallo-beta-lactamase (MBL)-producing strains","volume":"192","author":"Laupland","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jmii.2014.01.005_bib9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.diagmicrobio.2007.01.009","article-title":"Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa carrying metallo-beta-lactamase genes in Taiwan","volume":"59","author":"Huang","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2014.01.005_bib10","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3201\/eid0802.010244","article-title":"Current status of antimicrobial resistance in Taiwan","volume":"8","author":"Hsueh","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jmii.2014.01.005_bib11","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/jac\/dkr103","article-title":"Correlation between antibiotic consumption and resistance of Gram-negative bacteria causing healthcare-associated infections at a university hospital in Taiwan from 2000 to 2009","volume":"66","author":"Lai","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2014.01.005_bib12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.diagmicrobio.2003.10.005","article-title":"The status of antimicrobial resistance in Taiwan among gram-negative pathogens: the Taiwan surveillance of antimicrobial resistance (TSAR) program, 2000","volume":"48","author":"Lauderdale","year":"2004","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2014.01.005_bib13","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/1471-2334-12-200","article-title":"Emergence of extensively drug-resistant Acinetobacter baumannii complex over 10 years: nationwide data from the Taiwan Surveillance of Antimicrobial Resistance (TSAR) program","volume":"12","author":"Kuo","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jmii.2014.01.005_bib14","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jmii.2012.07.012","article-title":"Updated antibiotic resistance and clinical spectrum of infections caused by Streptococcus pneumoniae in Taiwan: emphasis on risk factors for penicillin nonsusceptibilities","volume":"46","author":"Tsai","year":"2013","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2014.01.005_bib15","series-title":"Performance standards for antimicrobial susceptibility testing","year":"2011"},{"key":"10.1016\/j.jmii.2014.01.005_bib16","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically","year":"2012"},{"key":"10.1016\/j.jmii.2014.01.005_bib17","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1128\/AAC.05991-11","article-title":"Prospective multicenter study of the impact of carbapenem resistance on mortality in Pseudomonas aeruginosa bloodstream infections","volume":"56","author":"Pena","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2014.01.005_bib18","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.diagmicrobio.2012.12.012","article-title":"Activities of carbapenem and comparator agents against contemporary US Pseudomonas aeruginosa isolates from the CAPITAL surveillance program","volume":"75","author":"Morrow","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2014.01.005_bib19","series-title":"Annual Report of Nosocomial Infections Surveillance System","year":"2011"},{"key":"10.1016\/j.jmii.2014.01.005_bib20","doi-asserted-by":"crossref","first-page":"e65621","DOI":"10.1371\/journal.pone.0065621","article-title":"Antibiotic consumption and healthcare-associated infections caused by multidrug-resistant gram-negative bacilli at a large medical center in taiwan from 2002 to 2009: implicating the importance of antibiotic stewardship","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jmii.2014.01.005_bib21","doi-asserted-by":"crossref","first-page":"95 e2","DOI":"10.1016\/j.ajic.2009.12.004","article-title":"International Nosocomial Infection Control Consortium (INICC) report, data summary for 2003\u20132008, issued June 2009","volume":"38","author":"Rosenthal","year":"2010","journal-title":"Am Journal Infect Control"},{"key":"10.1016\/j.jmii.2014.01.005_bib22","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1099\/jmm.0.009142-0","article-title":"Pseudomonas aeruginosa \u2013 a phenomenon of bacterial resistance","volume":"58","author":"Strateva","year":"2009","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.jmii.2014.01.005_bib23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.diagmicrobio.2007.01.009","article-title":"Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa carrying metallo-h-lactamase genes in Taiwan","volume":"59","author":"Huang","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2014.01.005_bib24","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.diagmicrobio.2012.09.018","article-title":"Impact of susceptibility profiles of Gram-negative bacteria before and after the introduction of ertapenem at a medical center in northern Taiwan from 2004 to 2010","volume":"75","author":"Lee","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2014.01.005_bib25","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1089\/mdr.2010.0170","article-title":"Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia: clinical impact of antimicrobial resistance on outcome","volume":"17","author":"Joo","year":"2011","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.jmii.2014.01.005_bib26","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1086\/507274","article-title":"Imipenem resistance among Pseudomonas aeruginosa isolates: risk factors for infection and impact of resistance on clinical and economic outcomes","volume":"27","author":"Lautenbach","year":"2006","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jmii.2014.01.005_bib27","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1128\/AAC.00464-08","article-title":"Fluoroquinolone enhances the mutation frequency for meropenem-selected carbapenem resistance in Pseudomonas aeruginosa, but use of the high-potency drug doripenem inhibits mutant formation","volume":"52","author":"Tanimoto","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2014.01.005_bib28","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1128\/AAC.43.2.424","article-title":"Carbapenem activities against Pseudomonas aeruginosa: respective contributions of OprD and efflux systems","volume":"43","author":"Kohler","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2014.01.005_bib29","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1128\/AAC.49.2.760-766.2005","article-title":"Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome","volume":"49","author":"Kang","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2014.01.005_bib30","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1086\/528712","article-title":"Outcomes of bacteremia due to Pseudomonas aeruginosa with reduced susceptibility to piperacillin-tazobactam: implications on the appropriateness of the resistance breakpoint","volume":"46","author":"Tam","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2014.01.005_bib31","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1378\/chest.11-0330","article-title":"Severity scoring in the critically ill: part 1 \u2013 interpretation and accuracy of outcome prediction scoring systems","volume":"141","author":"Breslow","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jmii.2014.01.005_bib32","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1099\/jmm.0.46548-0","article-title":"Invasive fungal infections: a review of epidemiology and management options","volume":"55","author":"Enoch","year":"2006","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.jmii.2014.01.005_bib33","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1086\/517976","article-title":"Effect of education on the rate of and the understanding of risk factors for intravascular catheter-related infections","volume":"28","author":"Yilmaz","year":"2007","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jmii.2014.01.005_bib34","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1128\/AAC.00207-10","article-title":"Impact of multidrug-resistant Pseudomonas aeruginosa bacteremia on patient outcomes","volume":"54","author":"Tam","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2014.01.005_bib35","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S1473-3099(10)70258-9","article-title":"Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study","volume":"11","author":"Lambert","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jmii.2014.01.005_bib36","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1086\/510075","article-title":"Does antibiotic selection impact patient outcome?","volume":"44","author":"Harbarth","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2014.01.005_bib37","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/jac\/dkr105","article-title":"Effect of multidrug resistance-conferring mutations on the fitness and virulence of Pseudomonas aeruginosa","volume":"66","author":"Abdelraouf","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2014.01.005_bib38","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2249.2003.02365.x","article-title":"Stimulation of innate immunity by susceptible and multidrug-resistant Pseudomonas aeruginosa: an in\u00a0vitro and in\u00a0vivo study","volume":"135","author":"Giamarellos-Bourboulis","year":"2004","journal-title":"Clin Exp Immunol"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118214000085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118214000085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:20:23Z","timestamp":1761657623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118214000085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S1684118214000085"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2014.01.005","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carbapenem-resistant Pseudomonas aeruginosa in Taiwan: Prevalence, risk factors, and impact on outcome of infections","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2014.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}